Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Operating Income: 2020-2025

Historic Operating Income for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $19.0 million.

  • Cellebrite DI's Operating Income fell 2.34% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.4 million, marking a year-over-year increase of 9.30%. This contributed to the annual value of $56.9 million for FY2024, which is 71.21% up from last year.
  • As of Q3 2025, Cellebrite DI's Operating Income stood at $19.0 million, which was up 31.72% from $14.4 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Operating Income registered a high of $19.4 million during Q3 2024, and its lowest value of $136,000 during Q1 2023.
  • Over the past 3 years, Cellebrite DI's median Operating Income value was $13.5 million (recorded in 2023), while the average stood at $12.3 million.
  • Its Operating Income has fluctuated over the past 5 years, first slumped by 93.01% in 2023, then skyrocketed by 6,699.26% in 2024.
  • Over the past 5 years, Cellebrite DI's Operating Income (Quarterly) stood at $4.3 million in 2021, then spiked by 124.66% to $9.7 million in 2022, then soared by 55.04% to $15.0 million in 2023, then climbed by 4.85% to $15.7 million in 2024, then dropped by 2.34% to $19.0 million in 2025.
  • Its last three reported values are $19.0 million in Q3 2025, $14.4 million for Q2 2025, and $12.3 million during Q1 2025.